Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges? What does the ‘2022/23 priorities and operational planning guidance’ document...
Read More
In the lead up to Christmas 2021, our UK market access team shared a daily insight, reflection, or comment on the NHS and the UK market access environment on our...
Read More
David Thorne (Director, Mtech Access and Business Development Director, Well Up North PCN) is featured in the Winter issue of Pf Magazine where he shares his views on the lessons...
Read More
What changes and innovations can we expect to see on the Veeva CRM in 2022, and what will they mean for market access and brand teams? Last week our digital...
Read More
Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how...
Read More
What is a Place in the new NHS structure? What role will Place leaders have in decision-making? What will this new structure mean for the way Pharma and Medtech engage...
Read More
Rob Pitt recently joined Mtech Access as a Developer working on our iPad applications, web-based tools and Veeva-integrated interactive presentations. These digital tools and presentation aids are used by our...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
On World Evidence-Based Healthcare Day (20th October 2021), we explore the role of evidence in an infodemic and how evidence generation processes have been accelerated to offer rapid yet robust...
Read More
How will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what...
Read More
